ICPT

ICPT Articles

Top analyst upgrades, downgrades and initiations for the first trading day of 2020 included Abbott Laboratories, Advanced Micro Devices, Analog Devices, Applied Materials, Ford, Illumina, Medtronic,...
Here, 24/7 Wall St. has included a calendar of a few of the biggest clinical trial and FDA updates to watch for going into 2020.
The top analyst upgrades, downgrades and initiations on Tuesday included Caesars, Chipotle Mexican Grill, Host Hotels, Kellogg, McDonald's, Shopify, Starbucks and Tiffany.
Intercept Pharmaceuticals was last seen trading higher after the company's financial reporting. While numbers are always important to see, a more subjective issue is a positive review from Wall...
Intercept Pharmaceuticals shares jumped on Tuesday after the firm announced results for its Phase 3 Regenerate study of obeticholic acid in patients with liver fibrosis due to nonalcoholic...
It's another disappointing day for one of America's top biotech companies. But that may prove to be great news for Intercept Pharmaceuticals.
The top analyst upgrades, downgrades and initiations seen on Tuesday included BHP, Cisco Systems, Crown Castle, Gilead Sciences, Goldcorp, Take-Two Interactive Software, Varonis Systems and Whiting...
The top analyst upgrades, downgrades and initiations seen om Monday included AON, Conoco, Groupon, Intuit, JinkoSolar, NextEra, WisdomTree, Xilinx and Yelp.
The top analyst upgrades, downgrades and initiations seen on Thursday included Allergan, Boeing, Facebook, GoPro, Microsoft, Pfizer, Royal Dutch Shell, ServiceNow and Tiffany.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Allergan, Apple, Carnival, Ciena, Juniper Networks, Lockheed Martin, Plug Power, Take-Two Interactive Software, United...
 Stocks were indicated to open lower on Monday after weekend news that sounds like a China trade deal is not on the way very soon. Investors have been forced to see numerous waves of selling in...
The top analyst upgrades, downgrades and initiations seen on Tuesday included Boston Scientific, Etsy, General Electric, Morgan Stanley, SeaWorld, Skechers, Shopify, Square and Tesla.
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates for the rest of March.
Merrill Lynch has taken a look at the biotech industry and made a few picks that could play out in 2018.
24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of March.